Prame is a tumor-associated antigen that was first identified in metastatic cutaneous melanoma and is subsequently found to frequently overexpress in various cancers, which also associates with advanced stages and poor clinical outcomes [14–16]. The gene discussed is PRAME; the disease is cancer.